Those with at least one measurable lesion and at least one tumor assessment after baseline were evaluable for response; patients with disease progression were also evaluable.
基线测量后，那些至少有一个可测量损伤或至少有一个肿瘤评估的患者可以评价反应；疾病进展的患者也可评价。
Those with at least one measurable lesion and at least one tumor assessment after baseline were evaluable for response; patients with disease progression were also evaluable.
基线测量后，那些至少有一个可测量损伤或至少有一个肿瘤评估的患者可以评价反应；疾病进展的患者也可评价。
应用推荐